Christopher Rand

Christopher Rand is an accomplished professional with an extensive background in intellectual property valuation and licensing. He holds an MBA from Vanderbilt University's Owen Graduate School of Management and a BBA in Accounting from the University of Notre Dame. With a strong educational foundation, Christopher has held various leadership roles in organizations across different industries.

Christopher Rand's professional journey includes serving as the CEO at AngelEye Health, Managing Director at Tri-Star Health Partners, and Director at several companies such as Satchel Health, InvisionHeart, WorkMeIn LLC, Carrot Medical, LLC, and Evermind, Inc. Additionally, he has been actively involved as a Board Member and Investor at AngelEye Health, highlighting his strategic business acumen and investment proficiency.

Prior to his executive positions, Christopher Rand was a Partner at TriStar Technology Ventures, where he likely honed his skills in identifying and nurturing high-potential technology startups. His experience as a Manager in New Venture Development at Vanderbilt Office of Enterprise Development showcases his expertise in fostering innovation and entrepreneurial initiatives.

Furthermore, Christopher Rand's tenure as a Senior Associate at Standard & Poor's underscores his financial acumen and analytical capabilities. His diverse professional background equips him with a unique perspective on business strategy, intellectual property management, and venture capital investment.

With a comprehensive skill set and a proven track record of leadership roles in notable organizations, Christopher Rand continues to be a prominent figure in the intellectual property and healthcare industries, contributing significantly to innovation, valuation, and strategic growth.